🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Cepheid

1 post
Oxford Nanopore Technologies’ portable DNA and RNA sequencing platform is expanding across genomics research, infectious-disease surveillance, pharmaceutical development and industrial biology. Representative image.
Read More

Oxford Nanopore Technologies company profile: How pocket-sized DNA sequencing became a global genomics platform

Oxford Nanopore Technologies has transformed DNA and RNA analysis through portable, real-time sequencing systems ranging from MinION to the high-throughput PromethION platform. Revenue reached £223.9 million in 2025, but slower first-half growth, declining liquid resources and full-year guidance that includes some non-recurring collaboration and licensing income have kept profitability under scrutiny.